U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.437C>G (p.Ser146Cys) AND Rett syndrome

Germline classification:
Pathogenic/Likely pathogenic (10 submissions)
Last evaluated:
Mar 8, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000133095.24

Allele description [Variation Report for NM_001110792.2(MECP2):c.437C>G (p.Ser146Cys)]

NM_001110792.2(MECP2):c.437C>G (p.Ser146Cys)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.437C>G (p.Ser146Cys)
Other names:
NM_001110792.2(MECP2):c.437C>G; p.Ser146Cys
HGVS:
  • NC_000023.11:g.154031427G>C
  • NG_007107.3:g.110677C>G
  • NM_001110792.2:c.437C>GMANE SELECT
  • NM_001316337.2:c.122C>G
  • NM_001369391.2:c.122C>G
  • NM_001369392.2:c.122C>G
  • NM_001369393.2:c.122C>G
  • NM_001369394.2:c.122C>G
  • NM_001386137.1:c.-160C>G
  • NM_001386138.1:c.-160C>G
  • NM_001386139.1:c.-160C>G
  • NM_004992.4:c.401C>G
  • NP_001104262.1:p.Ser146Cys
  • NP_001303266.1:p.Ser41Cys
  • NP_001356320.1:p.Ser41Cys
  • NP_001356321.1:p.Ser41Cys
  • NP_001356322.1:p.Ser41Cys
  • NP_001356323.1:p.Ser41Cys
  • NP_004983.1:p.Ser134Cys
  • NP_004983.1:p.Ser134Cys
  • LRG_764t1:c.437C>G
  • LRG_764t2:c.401C>G
  • AJ132917.1:c.401C>G
  • LRG_764:g.110677C>G
  • LRG_764p1:p.Ser146Cys
  • LRG_764p2:p.Ser134Cys
  • NC_000023.10:g.153296878G>C
  • NG_007107.2:g.110701C>G
  • NM_004992.3:c.401C>G
  • NM_004992.4:c.401C>G
  • P51608:p.Ser134Cys
Protein change:
S134C
Links:
UniProtKB: P51608#VAR_010278; dbSNP: rs61748390
NCBI 1000 Genomes Browser:
rs61748390
Molecular consequence:
  • NM_001386137.1:c.-160C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386138.1:c.-160C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001386139.1:c.-160C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001110792.2:c.437C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316337.2:c.122C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369391.2:c.122C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369392.2:c.122C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369393.2:c.122C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369394.2:c.122C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004992.4:c.401C>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
17

Condition(s)

Name:
Rett syndrome (RTT)
Synonyms:
Autism, dementia, ataxia, and loss of purposeful hand use; Rett's disorder
Identifiers:
MONDO: MONDO:0010726; MedGen: C0035372; Orphanet: 3095; Orphanet: 778; OMIM: 312750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000188085RettBASE
no assertion criteria provided
Pathogenic
(Nov 1, 2011)
maternal, de novo, unknowncuration

PubMed (10)
[See all records that cite these PMIDs]

SCV000247967Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2007)
Pathogenic
(Feb 8, 2013)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000537175Molecular Diagnostics Lab, Nemours Children's Health, Delaware
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jul 7, 2015)
de novoclinical testing

PubMed (10)
[See all records that cite these PMIDs]

SCV001362253Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Mar 11, 2021)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link,

SCV001427579Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
no assertion criteria provided
Pathogenic
(Jan 1, 2019)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002053932Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicde novoresearch

PubMed (1)
[See all records that cite this PMID]

SCV002107099DASA
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 5, 2022)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV002506805New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Pathogenic
(Jun 11, 2021)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link,

SCV004100763Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 9, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004808969Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Mar 8, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot provided1not providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation
not providedunknownyes9not providednot provided9Noclinical testing, curation
not providedunknownunknown1not providednot provided1not providedcuration
not providedde novoyes6not providednot provided5Noclinical testing, research, curation
not providedmaternalyes2not providednot provided2Yescuration
not providedunknownno1not providednot provided1Yescuration

Citations

PubMed

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.

Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee..

Genet Med. 2008 Apr;10(4):294-300. doi: 10.1097/GIM.0b013e31816b5cae.

PubMed [citation]
PMID:
18414213

Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.

Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I, Ohtsuka Y, Kuwajima K, Endo S, Iwai T, Yamagata H, Tabara Y, Miki T, Matsuishi T, Kondo I.

Brain Dev. 2005 Apr;27(3):211-7.

PubMed [citation]
PMID:
15737703
See all PubMed Citations (26)

Details of each submission

From RettBASE, SCV000188085.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedcuration PubMed (10)
2not provided1not providedYescuration PubMed (10)
3not provided1not providedYescuration PubMed (10)
4not provided1not providedNocuration PubMed (10)
5not provided1not providedNocuration PubMed (10)
6not provided1not providedNocuration PubMed (10)
7not provided1not providedNocuration PubMed (10)
8not provided1not providedNocuration PubMed (10)
9not provided1not providednot providedcuration PubMed (10)
10not provided1not providedNocuration PubMed (10)
11not provided1not providedNocuration PubMed (10)
12not provided1not providednot providedcuration PubMed (10)
13not provided1not providednot providedcuration PubMed (10)
14not provided1not providednot providedcuration PubMed (10)
15not provided1not providedNocuration PubMed (10)
16not provided1not providedYescuration PubMed (10)
17not provided1not providedNocuration PubMed (10)
18not provided1not providedNocuration PubMed (10)

Description

"Not Rett synd. - Unaffected family member"

Rett syndrome - Atypical

Rett syndrome - Atypical

Rett syndrome - classical

Rett syndrome - Classical

Rett syndrome - not certain

"Rett syndrome - Classical"
"Rett syndrome - Not certain"
"Rett syndrome - classical"
"Rett syndrome - Classical"
"Rett syndrome - not certain"
"Rett syndrome - Classical"
"Rett syndrome - Classical"
"Rett syndrome - Not certain"
"Rett syndrome - Male variant"
"Rett syndrome - not certain"
"Rett syndrome - Classical"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknown1bloodnot provided1not providednot providednot provided
2unknownno1bloodnot provided1not providednot providednot provided
3maternalyes1bloodnot provided1not providednot providednot provided
4de novoyes1bloodnot provided1not providednot providednot provided
5unknownyes1bloodnot provided1not providednot providednot provided
6de novoyes1not providednot provided1not providednot providednot provided
7unknownyes1bloodnot provided1not providednot providednot provided
8unknownyes1Bloodnot provided1not providednot providednot provided
9de novoyes1bloodnot provided1not providednot providednot provided
10de novoyes1bloodnot provided1not providednot providednot provided
11unknownyes1bloodnot provided1not providednot providednot provided
12unknownyes1bloodnot provided1not providednot providednot provided
13unknownyes1Blood or skinnot provided1not providednot providednot provided
14unknownyes1Blood or skinnot provided1not providednot providednot provided
15unknownyes1Bloodnot provided1not providednot providednot provided
16maternalyes1bloodnot provided1not providednot providednot provided
17de novoyes1bloodnot provided1not providednot providednot provided
18unknownyes1Bloodnot provided1not providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV000247967.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Molecular Diagnostics Lab, Nemours Children's Health, Delaware, SCV000537175.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (10)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001362253.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: MECP2 c.401C>G (p.Ser134Cys) results in a non-conservative amino acid change located in the Methyl-CpG DNA binding domain (IPR001739) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 181626 control chromosomes (gnomAD). c.401C>G has been reported in the literature in multiple individuals affected with Rett Syndrome, in some cases as a de novo mutation (example: Chapleau_2013, Li_2007, Neul_2008, Petel-Galil_2006, Roende_2011, Zahorakova_2007). These data indicate that the variant is very likely to be associated with disease. In functional studies, the variant has been reported to reduce the ability of the MECP2 protein to bind and cluster heterochromatin and was shown to cause destabilization of the methyl-CpG-binding domain of the protein (example: Agarwal_2011, Kucukkal_2015). Four other ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille, SCV001427579.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India, SCV002053932.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From DASA, SCV002107099.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (11)

Description

The c.401C>G;p.(Ser134Cys) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 143562; PMID: 10814718; PMID: 11738864; PMID: 17089071; PMID: 12655490; PMID: 21160487; PMID: 11738883; PMID: 18337588) - PS4. The variant is located in a mutational hot spot and/or critical and well-established functional domain (MBD) - PM1. This variant is not present in population databases (rs61748390- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. Pathogenic missense variant in this residue have been reported (ClinVar ID: 143563) - PM5. The variant was assumed de novo, but without confirmation of paternity and maternity (PMID: 10767337; 23696494; 22182064) - PM6. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From New York Genome Center - CSER-NYCKidSeq, SCV002506805.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)

Description

The heterozygous c.401C>G (p.Ser134Cys) missense variant identified in the MECP2 gene is a known pathogenic variant and has been reported in multiple unrelated individuals affected with Rett syndrome [PMID:10767337; PMID:12661945; PMID:21228398; PMID:26418480; PMID: 31164858]. The variant has been reported as Pathogenic/Likely Pathogenic in ClinVar by multiple independent laboratories [Variation ID: 143562]. The variant is absent from gnomAD(v3) suggesting it is not a common benign variant in the populations represented in that database. The variant affects an evolutionarily conserved residue and is predicted deleterious by multiple in silico prediction tools [CADD score = 27.7, REVEL score = 0.988). Functional studies have suggested that the c.401C>G (p.Ser134Cys) variant destabilizes the MBD domain of the MECP2 protein and reduces its ability to bind and cluster heterochromatin [PMID: 26418480; PMID: 21831886]. Based on the available evidence, the heterozygous c.401C>G (p.Ser134Cys) missense variant identified in the MECP2 gene is reported as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From Institute of Human Genetics, University of Leipzig Medical Center, SCV004100763.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Criteria applied: PS2_VSTR,PS4,PM5_STR,PM1,PM2_SUP,PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Centre for Population Genomics, CPG, SCV004808969.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: This variant has been identified as a de novo occurrence in at least 2 individuals with Rett syndrome, without confirmation of paternity and maternity (PM6_Strong). (PMID: 17089071, 10991688, 11269512) Has been observed in at least 5 individuals with phenotypes consistent with MECP2-related disease (PS4). PMID: 17407838, 17387578, 11269512, 17089071, 11738864, 10991688, 10814718, ClinVar Variation ID: 143562) Computational prediction analysis tools suggests a deleterious impact (REVEL score>= 0.75) (PP3). This variant is absent from gnomAD (PM2_Supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024